MedDataX Logo

Assessment of the Benefit of Teleconsultations for Children With Autism Spectrum Disorders

NCT ID: NCT02996708

Last Updated: 2016-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether Teleconsultation would a)be effective and cost-effective by increasing the proportion of patients with Autism Spectrum Disorders having a correct follow-up, and less transportation, and b) get a high satisfaction from the parents and from the professionals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder Child Autism

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Telemedicine Health economics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group with teleconsultation - before period

No interventions assigned to this group

Group without teleconsultation - before period

No interventions assigned to this group

Group with teleconsultation - after period

No interventions assigned to this group

Group without teleconsultation - after period

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All residents of medico-social structures accepting children and adolescent with autism disorders

Exclusion Criteria

* Refusal of parents that their child use telemedicine
* Refusal of parents that their child participate to the research
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Catherine Doyen, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpital Sainte Anne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IME notre Ecole

Carrières-sous-Poissy, , France

Site Status RECRUITING

Association Agir et Vivre l'Autisme

Chambourcy, , France

Site Status RECRUITING

IME Eclair

Collégien, , France

Site Status RECRUITING

Association UNI-TEDS

Dammarie-les-Lys, , France

Site Status RECRUITING

Hôpital Sainte Anne

Paris, , France

Site Status RECRUITING

IME Le Reverdi

Vert-Saint-Denis, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Isabelle Durand-Zaleski, MD, PhD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amélie Couteau

Role: primary

Stéphane Da

Role: primary

Liora CRESPIN

Role: primary

Slimane Haddadi

Role: primary

Catherine Doyen, MD

Role: primary

Christine CARNIAC

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TLM Prometted

Identifier Type: -

Identifier Source: org_study_id